Sorafenib CAS 284461-73-0 Tsarkakewa

Takaitaccen Bayani:

Name: Sorafenib

Saukewa: 284461-73-0

Bayyanar: Fari zuwa Kashe-fari foda

Tsafta: ≥99.0% (HPLC)

Sorafenib a cikin maganin RCC & HCC

API High Quality, Kasuwancin Kasuwanci

Inquiry: alvin@ruifuchem.com


Cikakken Bayani

Samfura masu dangantaka

Tags samfurin

Bayani:

Abubuwan Sinadarai:

Suna Sorafenib
Makamantu Sorafenib Free Base
Lambar CAS 284461-73-0
Lambar CAT RF-API04
Matsayin Hannun jari A Hannun jari, Ma'aunin Samfuran Har zuwa Daruruwan Kilogram
Tsarin kwayoyin halitta Saukewa: C21H16ClF3N4O3
Nauyin Kwayoyin Halitta 464.82
Yawan yawa 1.454± 0.06 g/cm3
Solubility Mai narkewa a cikin DMSO
Yanayin jigilar kaya Yanayin yanayi
Alamar Ruifu Chemical

Ƙayyadaddun bayanai:

Abu Ƙayyadaddun bayanai
Bayyanar Fari zuwa Kashe-Farin Foda
Tsarkake / Hanyar Bincike ≥99.0% (HPLC)
Ganewa H-NMR, MS
Asara akan bushewa ≤1.0%
Ragowa akan Ignition ≤0.10%
Tsaftace Guda Daya ≤0.20% (HPLC)
Jimlar ƙazanta ≤1.0% (HPLC)
Karfe masu nauyi ≤20ppm
Bayyanar Magani Yi daidai da Standard
Matsayin Gwaji Matsayin Kasuwanci
Amfani RCC & HCC

Kunshin & Ajiya:

Kunshin: Bottle, Aluminum tsare jakar, Kwali drum, 25kg / Drum, ko bisa ga abokin ciniki ta bukata.

Yanayin Ajiya:Ajiye a cikin kwantena da aka rufe a wuri mai sanyi da bushe;Kare daga haske, danshi da kamuwa da kwari.

Amfani:

1

FAQ:

Aikace-aikace:

Sorafenib Tosylate (CAS: 475207-59-1) wani sabon nau'i ne na magungunan rigakafin tumor da aka yi niyya da yawa, Kamfanin Magunguna na Bayer na Jamus ne ya ƙirƙira shi, kuma ya nuna faɗuwar aikin antitumor a cikin gwaje-gwajen dabbobi na asali.Ana samun Sorafenib a cikin allunan 200-MG don gudanar da baki kuma ana amfani dashi a cikin jiyya na RCC da HCC.Sorafenib Tosylate (CAS: 475207-59-1) na iya yin tasiri a lokaci guda tare da ƙwayoyin ƙwayar cuta da ƙwayar jini.Yana da tasirin antitumor sau biyu: yana iya toshe hanyoyin siginar siginar tantanin halitta wanda RAF/MEK/ERK ke shiga tsakani don hana haɓakar ƙwayar ƙwayar cuta kai tsaye, yayin da kuma yana hana VEGF da abubuwan haɓakar haɓakar platelet (PDGF) don hana samuwar sabon ƙwayar ƙwayar cuta. tasoshin, don haka a kaikaice yana hana haɓakar ƙwayar ƙwayar cuta.Sorafenib shine mai hana Raf-1 da B-RAF da kuma yawan tyrosine kinases.

Ku rubuta sakonku anan ku aiko mana